4//SEC Filing
BOSTON SCIENTIFIC CORP 4
Accession 0001225208-17-005151
$BSXCIK 0000885725operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 8:55 PM ET
Size
16.6 KB
Accession
0001225208-17-005151
Insider Transaction Report
Form 4
Bose Supratim
EVP & President, Asia-Pacific
Transactions
- Award
Deferred Stock Units
2017-02-28+12,219→ 12,219 totalExp: 2022-02-28→ Common Stock (12,219 underlying) - Award
Stock Option (Right to Buy)
2017-02-28+39,525→ 39,525 totalExercise: $24.55Exp: 2027-02-28→ Common Stock (39,525 underlying) - Award
Common Stock
2017-02-28+26,758→ 313,535 total - Exercise/Conversion
Common Stock
2017-02-28+6,766→ 320,301 total - Exercise/Conversion
Deferred Stock Units
2017-02-28−6,766→ 6,766 totalExp: 2018-02-28→ Common Stock (6,766 underlying) - Award
Performance Share Units
2017-02-28+12,405→ 12,405 totalFrom: 2018-12-31Exp: 2018-12-31→ Common Stock (12,405 underlying)
Footnotes (7)
- [F1]On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2016 and was subject to the completion of the concurrent three-year individual service period. On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
- [F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
- [F5]Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F6]On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018.
- [F7]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000885725
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 8:55 PM ET
- Size
- 16.6 KB